Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Correction: Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected.

Kohli A, Islam A, Moyes DL, Murciano C, Shen C, Challacombe SJ, Naglik JR.

PLoS One. 2020 Feb 19;15(2):e0229553. doi: 10.1371/journal.pone.0229553. eCollection 2020.

2.

Abundance and diversity of resistomes differ between healthy human oral cavities and gut.

Carr VR, Witherden EA, Lee S, Shoaie S, Mullany P, Proctor GB, Gomez-Cabrero D, Moyes DL.

Nat Commun. 2020 Feb 4;11(1):693. doi: 10.1038/s41467-020-14422-w.

3.

Candidalysin Is Required for Neutrophil Recruitment and Virulence During Systemic Candida albicans Infection.

Swidergall M, Khalaji M, Solis NV, Moyes DL, Drummond RA, Hube B, Lionakis MS, Murdoch C, Filler SG, Naglik JR.

J Infect Dis. 2019 Sep 26;220(9):1477-1488. doi: 10.1093/infdis/jiz322.

4.

Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor.

Ho J, Yang X, Nikou SA, Kichik N, Donkin A, Ponde NO, Richardson JP, Gratacap RL, Archambault LS, Zwirner CP, Murciano C, Henley-Smith R, Thavaraj S, Tynan CJ, Gaffen SL, Hube B, Wheeler RT, Moyes DL, Naglik JR.

Nat Commun. 2019 May 24;10(1):2297. doi: 10.1038/s41467-019-09915-2.

5.

IL-36 and IL-1/IL-17 Drive Immunity to Oral Candidiasis via Parallel Mechanisms.

Verma AH, Zafar H, Ponde NO, Hepworth OW, Sihra D, Aggor FEY, Ainscough JS, Ho J, Richardson JP, Coleman BM, Hube B, Stacey M, McGeachy MJ, Naglik JR, Gaffen SL, Moyes DL.

J Immunol. 2018 Jul 15;201(2):627-634. doi: 10.4049/jimmunol.1800515. Epub 2018 Jun 11.

6.

Candida innate immunity at the mucosa.

Richardson JP, Moyes DL, Ho J, Naglik JR.

Semin Cell Dev Biol. 2019 May;89:58-70. doi: 10.1016/j.semcdb.2018.02.026. Epub 2018 Mar 9. Review.

PMID:
29501618
7.

The Human Mucosal Mycobiome and Fungal Community Interactions.

Witherden EA, Shoaie S, Hall RA, Moyes DL.

J Fungi (Basel). 2017 Oct 7;3(4). pii: E56. doi: 10.3390/jof3040056. Review.

8.

Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence.

Richardson JP, Mogavero S, Moyes DL, Blagojevic M, Krüger T, Verma AH, Coleman BM, De La Cruz Diaz J, Schulz D, Ponde NO, Carrano G, Kniemeyer O, Wilson D, Bader O, Enoiu SI, Ho J, Kichik N, Gaffen SL, Hube B, Naglik JR.

mBio. 2018 Jan 23;9(1). pii: e02178-17. doi: 10.1128/mBio.02178-17.

9.

Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa.

Richardson JP, Willems HME, Moyes DL, Shoaie S, Barker KS, Tan SL, Palmer GE, Hube B, Naglik JR, Peters BM.

Infect Immun. 2018 Jan 22;86(2). pii: e00645-17. doi: 10.1128/IAI.00645-17. Print 2018 Feb.

10.

Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin.

Verma AH, Richardson JP, Zhou C, Coleman BM, Moyes DL, Ho J, Huppler AR, Ramani K, McGeachy MJ, Mufazalov IA, Waisman A, Kane LP, Biswas PS, Hube B, Naglik JR, Gaffen SL.

Sci Immunol. 2017 Nov 3;2(17). pii: eaam8834. doi: 10.1126/sciimmunol.aam8834.

11.

The Role of ErbB Receptors in Infection.

Ho J, Moyes DL, Tavassoli M, Naglik JR.

Trends Microbiol. 2017 Nov;25(11):942-952. doi: 10.1016/j.tim.2017.04.009. Epub 2017 May 15. Review.

PMID:
28522156
12.

Candidalysin is a fungal peptide toxin critical for mucosal infection.

Moyes DL, Wilson D, Richardson JP, Mogavero S, Tang SX, Wernecke J, Höfs S, Gratacap RL, Robbins J, Runglall M, Murciano C, Blagojevic M, Thavaraj S, Förster TM, Hebecker B, Kasper L, Vizcay G, Iancu SI, Kichik N, Häder A, Kurzai O, Luo T, Krüger T, Kniemeyer O, Cota E, Bader O, Wheeler RT, Gutsmann T, Hube B, Naglik JR.

Nature. 2016 Apr 7;532(7597):64-8. doi: 10.1038/nature17625. Epub 2016 Mar 30.

13.

Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface.

Moyes DL, Richardson JP, Naglik JR.

Virulence. 2015;6(4):338-46. doi: 10.1080/21505594.2015.1012981. Review.

14.

Dermatophytes activate skin keratinocytes via mitogen-activated protein kinase signaling and induce immune responses.

Achterman RR, Moyes DL, Thavaraj S, Smith AR, Blair KM, White TC, Naglik JR.

Infect Immun. 2015 Apr;83(4):1705-14. doi: 10.1128/IAI.02776-14. Epub 2015 Feb 9.

15.

Adaptive immune responses to Candida albicans infection.

Richardson JP, Moyes DL.

Virulence. 2015;6(4):327-37. doi: 10.1080/21505594.2015.1004977. Epub 2015 Jan 21. Review.

16.

Candida albicans pathogenicity and epithelial immunity.

Naglik JR, Richardson JP, Moyes DL.

PLoS Pathog. 2014 Aug 14;10(8):e1004257. doi: 10.1371/journal.ppat.1004257. eCollection 2014 Aug. Review. No abstract available.

17.

Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.

Kohli A, Islam A, Moyes DL, Murciano C, Shen C, Challacombe SJ, Naglik JR.

PLoS One. 2014 May 23;9(5):e98077. doi: 10.1371/journal.pone.0098077. eCollection 2014. Erratum in: PLoS One. 2020 Feb 19;15(2):e0229553.

18.

Protection against epithelial damage during Candida albicans infection is mediated by PI3K/Akt and mammalian target of rapamycin signaling.

Moyes DL, Shen C, Murciano C, Runglall M, Richardson JP, Arno M, Aldecoa-Otalora E, Naglik JR.

J Infect Dis. 2014 Jun 1;209(11):1816-26. doi: 10.1093/infdis/jit824. Epub 2013 Dec 19.

19.

Clotrimazole dampens vaginal inflammation and neutrophil infiltration in response to Candida albicans infection.

Wilson D, Hebecker B, Moyes DL, Miramón P, Jablonowski N, Wisgott S, Allert S, Naglik JR, Hube B.

Antimicrob Agents Chemother. 2013 Oct;57(10):5178-80. doi: 10.1128/AAC.01244-13. Epub 2013 Jul 29.

20.

The mycobiome: influencing IBD severity.

Moyes DL, Naglik JR.

Cell Host Microbe. 2012 Jun 14;11(6):551-2. doi: 10.1016/j.chom.2012.05.009. Review.

Supplemental Content

Loading ...
Support Center